List of Metaproteomics patents

Patents where

Current Assignee

Name

‌

Metaproteomics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8142819 Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response	Patent 8142819 was granted and assigned to Metaproteomics on March, 2012 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	8142819	March 27, 2012
‌ US Patent 7270835 Compositions that treat or inhibit pathological conditions associated with inflammatory response	Patent 7270835 was granted and assigned to Metaproteomics on September, 2007 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7270835	September 18, 2007
‌ US Patent 7332185 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2	Patent 7332185 was granted and assigned to Metaproteomics on February, 2008 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7332185	February 19, 2008
‌ US Patent 7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2	Patent 7195785 was granted and assigned to Metaproteomics on March, 2007 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7195785	March 27, 2007
‌ US Patent 7205151 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2	Patent 7205151 was granted and assigned to Metaproteomics on April, 2007 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7205151	April 17, 2007
‌ US Patent 7736677 Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment	Patent 7736677 was granted and assigned to Metaproteomics on June, 2010 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7736677	June 15, 2010
‌ US Patent 7820206 Modulation of inflammation by hops fractions and derivatives	Patent 7820206 was granted and assigned to Metaproteomics on October, 2010 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7820206	October 26, 2010
‌ US Patent 7722903 Modulation of inflammation by hops fractions and derivatives	Patent 7722903 was granted and assigned to Metaproteomics on May, 2010 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7722903	May 25, 2010
‌ US Patent 7815944 Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity	Patent 7815944 was granted and assigned to Metaproteomics on October, 2010 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7815944	October 19, 2010
‌ US Patent 8168234 Compositions that treat or inhibit pathological conditions associated with inflammatory response	Patent 8168234 was granted and assigned to Metaproteomics on May, 2012 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	8168234	May 1, 2012
‌ US Patent 8486457 Compositions that treat or inhibit pathological conditions associated with inflammatory response	Patent 8486457 was granted and assigned to Metaproteomics on July, 2013 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	8486457	July 16, 2013
‌ US Patent 8257754 Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response	Patent 8257754 was granted and assigned to Metaproteomics on September, 2012 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	8257754	September 4, 2012
‌ US Patent 7666449 Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity	Patent 7666449 was granted and assigned to Metaproteomics on February, 2010 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7666449	February 23, 2010
‌ US Patent 7811610 Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity	Patent 7811610 was granted and assigned to Metaproteomics on October, 2010 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7811610	October 12, 2010
‌ US Patent 7901714 Treatment modalities for autoimmune diseases	Patent 7901714 was granted and assigned to Metaproteomics on March, 2011 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7901714	March 8, 2011
‌ US Patent 7718198 Treatment modalities for autoimmune diseases	Patent 7718198 was granted and assigned to Metaproteomics on May, 2010 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7718198	May 18, 2010
‌ US Patent 8815306 Methods and compositions for promoting bone and joint health	Patent 8815306 was granted and assigned to Metaproteomics on August, 2014 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	8815306	August 26, 2014
‌ US Patent 8206753 Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes	Patent 8206753 was granted and assigned to Metaproteomics on June, 2012 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	8206753	June 26, 2012
‌ US Patent 8475850 Methods and compositions for heavy metal detoxification	Patent 8475850 was granted and assigned to Metaproteomics on July, 2013 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	8475850	July 2, 2013
‌ US Patent 7914831 Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines	Patent 7914831 was granted and assigned to Metaproteomics on March, 2011 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7914831	March 29, 2011
‌ US Patent 7682636 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2	Patent 7682636 was granted and assigned to Metaproteomics on March, 2010 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7682636	March 23, 2010
‌ US Patent 8092846 Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines	Patent 8092846 was granted and assigned to Metaproteomics on January, 2012 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	8092846	January 10, 2012
‌ US Patent 8846115 Anti-inflammatory cyclooxygenase inhibitors	Patent 8846115 was granted and assigned to Metaproteomics on September, 2014 by the United States Patent and Trademark Office.	‌ Metaproteomics	‌ Metaproteomics	United States Patent and Trademark Office	8846115	September 30, 2014
‌ US Patent 7790205 Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response	Patent 7790205 was granted and assigned to Metaproteomics on September, 2010 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7790205	September 7, 2010
‌ US Patent 7919125 Modulation of inflammation by hops fractions and derivatives	Patent 7919125 was granted and assigned to Metaproteomics on April, 2011 by the United States Patent and Trademark Office.		‌ Metaproteomics	United States Patent and Trademark Office	7919125	April 5, 2011

Results per page:

33 results

0 selected

33 results

0 selected